Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Bentz, Cliff [R-OR-2]

Rep. Bentz, Cliff [R-OR-2]

United States · Official source

Records

391 records where Rep. Bentz, Cliff [R-OR-2] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 10647 (119th)referred

IMD CARE Act

United States · United States Congress · 1 October 2026

Bill· HRH.R. 9535 (119th)referred

Securing Agriculture's Workforce Act of 2026

United States · United States Congress · 30 June 2026

Securing Agriculture's Workforce Act of 2026 This bill expands the H-2A agricultural visa program; creates online platforms for H-2A employers, workers, and agencies; and codifies certain wage calculations. Under current law, workers on H-2A visas are only allowed to perform agricultural work of a seasonal or temporary nature. Under the bill, the seasonal work requirement is removed, thus allowing H-2A workers to qualify for agricultural work that occurs year-round. The bill also expands the type of agricultural work that qualifies, including reforestation, aquaculture, and livestock work. The Department of Agriculture must issue rules to define agricultural labor or services for purposes of the H-2A program. The bill also establishes an H-2A visa pathway for current unauthorized agricultural workers who otherwise meet requirements. The Department of Labor must maintain a national, publicly accessible online job registry and database of all job offers submitted by employers seeking a labor certification required to employ H-2A workers. The Department of Homeland Security must establish an online platform for employers to submit information and documentation for review by federal agencies in the course of admitting H-2A workers. The H-2A program requires employers to provide workers with wage rates at or above those set in regulations and such wages must not adversely affect the wages and working conditions of workers similarly employed in the United States. The bill codifies the current calculation method for the adverse effect wage rate as set in regulation. 

Bill· HRH.R. 8271 (119th)referred

ICU Bed Act of 2026

United States · United States Congress · 14 April 2026

Resolution· HRESH.Res. 1073 (119th)referred

Expressing support for the designation of February 21 through February 28, 2026, as "National FFA Week", recognizing the important role of the National Future Farmers of America (FFA) Organization in developing the next generation of globally conscious leaders who will change the world, and celebrating the 50th anniversary of the chartering of the State of Alaska as a State FFA Association.

United States · United States Congress · 23 February 2026

This resolution supports the designation of National FFA (Future Farmers of America) Week. It also celebrates the 50th anniversary of the chartering of Alaska as a State FFA Association of the National FFA Organization.

Bill· HRH.R. 7603 (119th)referred

O&C Renewal Act of 2026

United States · United States Congress · 20 February 2026

Bill· HRH.R. 7356 (119th)referred

To amend the Help America Vote Act of 2002 to prohibit the use of Federal funds for election administration in States that permit ballot harvesting.

United States · United States Congress · 4 February 2026

No Federal Funds for Ballot Harvesting Act This bill requires each state, in order to receive federal funds for election administration, to prohibit the knowing collection and transmission of a ballot in a federal election that was mailed to another person (commonly referred to as ballot harvesting), with exceptions.

Bill· HRH.R. 7008 (119th)open

Stop Insider Trading Act

United States · United States Congress · 12 January 2026

Stop Insider Trading Act This bill generally prohibits Members of Congress and their spouses and dependent children from purchasing stocks and requires public notice before these individuals may sell stocks. Specifically, Members of Congress and the spouses and dependent children of Members of Congress may not purchase covered investments. Between 7 and 14 days before a Member or a covered spouse or dependent sells a covered investment, the relevant Member must file public notice of the intent to sell with the Clerk of the House of Representatives or the Secretary of the Senate, as appropriate. The Clerk or Secretary must publish this notice online. If the individual decides not to sell the covered investment, the notice must be withdrawn. Under the bill, a covered investment is a security issued by a publicly traded company or a comparable economic interest. Some investments are exempt, including interest in a widely held investment fund and certain investments held in a trust. Violations of these provisions are subject to a fee and, in the case of a purchase, a requirement to sell the covered investment. The fee must equal (1) the greater of $2,000 or 10% of the transaction value, and (2) any net gain realized from the transaction during a specified period. The fee may not be paid using campaign donations or Members’ official allowances. Certain transactions by covered spouses and dependents are exempt, including transactions made on behalf of another person or made as part of compensation from the individual’s employer.

Bill· HRH.R. 6290 (119th)open

Safe Social Media Act

United States · United States Congress · 25 November 2025

Bill· HRH.R. 6130 (119th)referred

ASAP Act

United States · United States Congress · 19 November 2025

Bill· HRH.R. 5401 (119th)referred

Pay Our Troops Act of 2026

United States · United States Congress · 16 September 2025

Pay Our Troops Act of 2026 This bill provides continuing appropriations for military pay for any period during which interim or full-year appropriations for FY2026 are not in effect (i.e., a government shutdown). Specifically, the bill provides FY2026 continuing appropriations for the pay and allowances of (1) members of the Armed Forces, including reserve components, who perform active service during the period; and (2) civilian personnel and contractors of the Department of Defense (and the Department of Homeland Security in the case of the Coast Guard) who are providing support to such members of the Armed Forces. If a government shutdown occurs, the bill provides the continuing appropriations until the earlier of (1) the enactment into law of specified appropriations legislation, or (2) January 1, 2027. 

Resolution· HRESH.Res. 719 (119th)passed

Honoring the life and legacy of Charles Charlie James Kirk.

United States · United States Congress · 16 September 2025

This resolution (1) condemns the assassination of Charles "Charlie" James Kirk and all forms of political violence; and (2) honors the life, leadership, and legacy of Charlie Kirk.

Bill· HRH.R. 5343 (119th)reported

Ensuring Patient Access to Critical Breakthrough Products Act

United States · United States Congress · 15 September 2025

Ensuring Patient Access to Critical Breakthrough Products Act This bill provides for Medicare coverage of medical devices that are approved under the Food and Drug Administration (FDA) Breakthrough Devices Program. (Under the program, manufacturers work with the FDA to expedite the review and approval of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions.) The bill allows designated medical breakthrough devices to be temporarily covered under Medicare during a four-year transitional period. Manufacturers must apply to the Centers for Medicare & Medicaid Services (CMS) to receive this designation. Qualifying devices must (1) have received priority review from the FDA, (2) received premarket approval (if applicable) based on clinical data that includes data from Medicare beneficiaries, (3) already generally qualify for Medicare coverage, and (4) not present an undue risk of harm that outweighs potential clinical benefits for Medicare beneficiaries. The CMS must approve or deny applications within six months of receipt and must provide an explanation in the case of a denial. In addition, the CMS must make permanent coverage decisions before the end of the transitional period upon a timely request to do so, as specified. The bill provides funds through FY2030 for the CMS to implement the bill.

Bill· HRH.R. 5267 (119th)reported

American Franchise Act

United States · United States Congress · 10 September 2025

Bill· HRH.R. 5269 (119th)referred

RESULTS Act

United States · United States Congress · 10 September 2025

Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 or the RESULTS Act This bill requires the use of particular data from the private sector to inform Medicare payment rates for certain widely available laboratory tests.  Specifically, the Centers for Medicare & Medicaid Services (CMS) must contract with an entity that maintains a database of claims data for clinical diagnostic laboratory tests that (1) are not advanced diagnostic tests, and (2) were furnished by more than 100 providers and suppliers of such services over a specified six-month period (i.e., widely available tests). The database must meet specified requirements, such as having data that is representative of the entire country and from more than 50 private payors and claims administrators. The contracted entity must be a nonprofit entity that is not affiliated with any government agency, any insurance issuer or provider, or any other organization in the health care sector.  Beginning January 1, 2028, the CMS must use the information obtained from the database to inform Medicare payment rates for these widely available laboratory tests.  The bill additionally specifies processes for determining payment rates for laboratory tests that are not advanced diagnostic tests, are not widely available, and lack adequate claims data. The CMS must use certain existing processes to set appropriate rates. The bill also delays scheduled payment reductions for laboratory tests until 2028 and allows for judicial and administrative review of payment rates. 

Bill· HRH.R. 5221 (119th)open

PART Act

United States · United States Congress · 9 September 2025

Bill· HRH.R. 5160 (119th)open

Stem Cell Therapeutic and Research Reauthorization Act of 2025

United States · United States Congress · 4 September 2025

Stem Cell Therapeutic and Research Reauthorization Act of 2025 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Bill· HRH.R. 4424 (119th)referred

SHIELD Act

United States · United States Congress · 16 July 2025

Bill· HRH.R. 4370 (119th)referred

SAMS Act of 2025

United States · United States Congress · 14 July 2025

Bill· HRH.R. 4348 (119th)open

To reauthorize the Kay Hagan Tick Act, and for other purposes.

United States · United States Congress · 10 July 2025

This bill reauthorizes through FY2030 activities of the Centers for Disease Control and Prevention to address vector-borne diseases (e.g., diseases spread by bites from ticks or mosquitoes). These activities include (1) a national strategy, (2) grants for regional centers of excellence, and (3) cooperative agreements with state, local, and tribal health departments to increase capacity for preventing and responding to vector-borne diseases.

Bill· HRH.R. 4317 (119th)referred

PBM Reform Act of 2025

United States · United States Congress · 10 July 2025

Bill· HRH.R. 3946 (119th)referred

FIGHT Act of 2025

United States · United States Congress · 12 June 2025

Bill· HRH.R. 3699 (119th)open

Energy Choice Act

United States · United States Congress · 4 June 2025